BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

412 related articles for article (PubMed ID: 22541833)

  • 1. Transplant registrants with implanted left ventricular assist devices have insufficient risk to justify elective organ procurement and transplantation network status 1A time.
    Dardas T; Mokadam NA; Pagani F; Aaronson K; Levy WC
    J Am Coll Cardiol; 2012 Jul; 60(1):36-43. PubMed ID: 22541833
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impact of ventricular assist device complications on posttransplant survival: an analysis of the United network of organ sharing database.
    Healy AH; Baird BC; Drakos SG; Stehlik J; Selzman CH
    Ann Thorac Surg; 2013 Mar; 95(3):870-5. PubMed ID: 23218024
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effectiveness of United Network of Organ Sharing status 2 transplantation in the modern era.
    Dardas TF; Cowger J; Koelling TM; Aaronson KD; Pagani FD
    J Heart Lung Transplant; 2011 Oct; 30(10):1169-74. PubMed ID: 21621422
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Post-cardiac transplant survival after support with a continuous-flow left ventricular assist device: impact of duration of left ventricular assist device support and other variables.
    John R; Pagani FD; Naka Y; Boyle A; Conte JV; Russell SD; Klodell CT; Milano CA; Rogers J; Farrar DJ; Frazier OH
    J Thorac Cardiovasc Surg; 2010 Jul; 140(1):174-81. PubMed ID: 20447659
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Morbidity and mortality in heart transplant candidates supported with mechanical circulatory support: is reappraisal of the current United network for organ sharing thoracic organ allocation policy justified?
    Wever-Pinzon O; Drakos SG; Kfoury AG; Nativi JN; Gilbert EM; Everitt M; Alharethi R; Brunisholz K; Bader FM; Li DY; Selzman CH; Stehlik J
    Circulation; 2013 Jan; 127(4):452-62. PubMed ID: 23271796
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The use of mechanical circulatory support as a bridge to transplantation in pediatric patients: an analysis of the United Network for Organ Sharing database.
    Davies RR; Russo MJ; Hong KN; O'Byrne ML; Cork DP; Moskowitz AJ; Gelijns AC; Mital S; Mosca RS; Chen JM
    J Thorac Cardiovasc Surg; 2008 Feb; 135(2):421-7, 427.e1. PubMed ID: 18242279
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Should patients 60 years and older undergo bridge to transplantation with continuous-flow left ventricular assist devices?
    Allen JG; Kilic A; Weiss ES; Arnaoutakis GJ; George TJ; Shah AS; Conte JV
    Ann Thorac Surg; 2012 Dec; 94(6):2017-24. PubMed ID: 22858277
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effect of ventricular assist devices on post-transplant mortality an analysis of the United network for organ sharing thoracic registry.
    Patlolla V; Patten RD; Denofrio D; Konstam MA; Krishnamani R
    J Am Coll Cardiol; 2009 Jan; 53(3):264-71. PubMed ID: 19147043
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Improved survival and decreasing incidence of adverse events with the HeartMate II left ventricular assist device as bridge-to-transplant therapy.
    John R; Kamdar F; Liao K; Colvin-Adams M; Boyle A; Joyce L
    Ann Thorac Surg; 2008 Oct; 86(4):1227-34; discussion 1234-5. PubMed ID: 18805167
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Risk factors for mortality or delisting of patients from the pediatric heart transplant waiting list.
    Jeewa A; Manlhiot C; Kantor PF; Mital S; McCrindle BW; Dipchand AI
    J Thorac Cardiovasc Surg; 2014 Jan; 147(1):462-8. PubMed ID: 24183905
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Differential impact on post-transplant outcomes between pulsatile- and continuous-flow left ventricular assist devices.
    Ventura PA; Alharethi R; Budge D; Reid BB; Horne BD; Mason NO; Stoker S; Caine WT; Rasmusson B; Doty J; Clayson SE; Kfoury AG
    Clin Transplant; 2011; 25(4):E390-5. PubMed ID: 21401721
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Improved survival of patients with end-stage heart failure listed for heart transplantation: analysis of organ procurement and transplantation network/U.S. United Network of Organ Sharing data, 1990 to 2005.
    Lietz K; Miller LW
    J Am Coll Cardiol; 2007 Sep; 50(13):1282-90. PubMed ID: 17888847
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Optimal timing of cardiac transplantation after ventricular assist device implantation.
    Gammie JS; Edwards LB; Griffith BP; Pierson RN; Tsao L
    J Thorac Cardiovasc Surg; 2004 Jun; 127(6):1789-99. PubMed ID: 15173738
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impact of increased time at the highest urgency category on heart transplant outcomes for candidates with ventricular assist devices.
    Colvin M; Miranda-Herrera D; Gustafson SK; Heubner B; Skeans M; Wang X; Snyder JJ; Kasiske BL; Israni AK
    J Heart Lung Transplant; 2016 Mar; 35(3):326-334. PubMed ID: 26520245
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Do Patients Supported With Continuous-flow Left Ventricular Assist Device Have a Sufficient Risk of Death to Justify a Priority Allocation? A Propensity Score Matched Analysis of Patients Listed in UNOS Status 2.
    Mastrobuoni S; Dell'Aquila AM; Van Caenegem O; Poncelet A; Jacquet LM; Garcia J
    Transplantation; 2018 Jun; 102(6):e288-e294. PubMed ID: 29346259
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Changing outcomes in patients bridged to heart transplantation with continuous- versus pulsatile-flow ventricular assist devices: an analysis of the registry of the International Society for Heart and Lung Transplantation.
    Nativi JN; Drakos SG; Kucheryavaya AY; Edwards LB; Selzman CH; Taylor DO; Hertz MI; Kfoury AG; Stehlik J
    J Heart Lung Transplant; 2011 Aug; 30(8):854-61. PubMed ID: 21571550
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Continuous flow left ventricular assist device technology has influenced wait times and affected donor allocation in cardiac transplantation.
    Taghavi S; Jayarajan SN; Komaroff E; Mangi AA
    J Thorac Cardiovasc Surg; 2014 Jun; 147(6):1966-71, 1971.e1. PubMed ID: 24613158
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Right ventricular failure in patients with the HeartMate II continuous-flow left ventricular assist device: incidence, risk factors, and effect on outcomes.
    Kormos RL; Teuteberg JJ; Pagani FD; Russell SD; John R; Miller LW; Massey T; Milano CA; Moazami N; Sundareswaran KS; Farrar DJ;
    J Thorac Cardiovasc Surg; 2010 May; 139(5):1316-24. PubMed ID: 20132950
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long-term outcome of high-urgency heart transplant patients with and without temporary ventricular assist device support.
    Castel MA; Cartañá R; Cardona M; Pereda D; Hernández M; Sandoval E; Castella M; Pérez-Villa F
    Transplant Proc; 2012 Nov; 44(9):2642-4. PubMed ID: 23146481
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Survival after biventricular assist device implantation: an analysis of the Interagency Registry for Mechanically Assisted Circulatory Support database.
    Cleveland JC; Naftel DC; Reece TB; Murray M; Antaki J; Pagani FD; Kirklin JK
    J Heart Lung Transplant; 2011 Aug; 30(8):862-9. PubMed ID: 21621423
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.